Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains

K Urbanek, M Kolar, Y Loveckova, J Strojil, L Santava

. 2007 ; 32 (4 Aug) : 403-408.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc10012708

BACKGROUND: Klebsiella pneumoniae belongs to important nosocomial pathogens causing mainly hospital-acquired infections. Beta-lactam antibiotics are frequently used in the treatment of infections caused by K. pneumoniae, but by their selection pressure the bacteria become resistant. Excessive use of third-generation cephalosporins is a risk factor for the occurrence and spread of ESBL-producing bacterial strains. The goal of this study was to describe the utilization of third-generation cephalosporins and to analyse their selection pressure on K. pneumoniae in the University Hospital in Olomouc. METHODS: Data on the utilization of antibiotics in the hospital were obtained for the period 1997-2005 from the computerized database and expressed in defined daily doses per 100 bed-days (DBD). The data were processed according to the ATC/DDD system. Klebsiella pneumoniae strains were isolated from clinical material obtained from hospitalized patients. RESULTS: Consumption of third-generation cephalosporins, which was 1.79 DBD in 1997, decreased to 0.93 in 1999, remained stable until 2002, and then increased to 2.40 DBD in 2005. During the 9-year period analysed, a total of 9564 strains of K. pneumoniae were isolated. The ESBL-positive K. pneumoniae strains frequency increased from 8% to 18%. CONCLUSIONS: Increasing utilization of third-generation cephalosporins was associated with a statistically and clinically significant increased incidence of ESBL-positive K. pneumoniae strains.

000      
03299naa 2200445 a 4500
001      
bmc10012708
003      
CZ-PrNML
005      
20121123112542.0
008      
100526s2007 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Urbánek, Karel, $d 1969- $7 xx0078289
245    10
$a Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains / $c K Urbanek, M Kolar, Y Loveckova, J Strojil, L Santava
314    __
$a Department of Pharmacology, Faculty of Medicine and University Hospital, Olomouc, Czech Republic. urbanek@fnol.cz
520    9_
$a BACKGROUND: Klebsiella pneumoniae belongs to important nosocomial pathogens causing mainly hospital-acquired infections. Beta-lactam antibiotics are frequently used in the treatment of infections caused by K. pneumoniae, but by their selection pressure the bacteria become resistant. Excessive use of third-generation cephalosporins is a risk factor for the occurrence and spread of ESBL-producing bacterial strains. The goal of this study was to describe the utilization of third-generation cephalosporins and to analyse their selection pressure on K. pneumoniae in the University Hospital in Olomouc. METHODS: Data on the utilization of antibiotics in the hospital were obtained for the period 1997-2005 from the computerized database and expressed in defined daily doses per 100 bed-days (DBD). The data were processed according to the ATC/DDD system. Klebsiella pneumoniae strains were isolated from clinical material obtained from hospitalized patients. RESULTS: Consumption of third-generation cephalosporins, which was 1.79 DBD in 1997, decreased to 0.93 in 1999, remained stable until 2002, and then increased to 2.40 DBD in 2005. During the 9-year period analysed, a total of 9564 strains of K. pneumoniae were isolated. The ESBL-positive K. pneumoniae strains frequency increased from 8% to 18%. CONCLUSIONS: Increasing utilization of third-generation cephalosporins was associated with a statistically and clinically significant increased incidence of ESBL-positive K. pneumoniae strains.
650    _2
$a cefalosporiny $x aplikace a dávkování $x terapeutické užití $7 D002511
650    _2
$a infekce spojené se zdravotní péčí $x mikrobiologie $7 D003428
650    _2
$a databáze faktografické $7 D016208
650    _2
$a hodnocení spotřeby léčiv $7 D017723
650    _2
$a nemocnice univerzitní $7 D006785
650    _2
$a lidé $7 D006801
650    _2
$a infekce bakteriemi rodu Klebsiella $x farmakoterapie $x mikrobiologie $7 D007710
650    _2
$a Klebsiella pneumoniae $x účinky léků $7 D007711
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a beta-laktamová rezistence $7 D018440
650    _2
$a beta-laktamasy $x analýza $x metabolismus $7 D001618
650    _2
$a financování organizované $7 D005381
651    _2
$a Česká republika $7 D018153
700    1_
$a Kolář, Milan, $d 1964- $7 jn20010310083
700    1_
$a Lovečková, Yvona, $d 1965- $7 xx0073944
700    1_
$a Strojil, Jan, $d 1978- $7 xx0107792
700    1_
$a Šantavá, Lucie. $7 xx0211051
773    0_
$t Journal of Clinical Pharmacy & Therapeutics $w MED00007277 $g Roč. 32, č. 4 Aug (2007), s. 403-408 $x 0269-4727
910    __
$a ABA008 $b x $y 8
990    __
$a 20100531112736 $b ABA008
991    __
$a 20121123112605 $b ABA008
999    __
$a ok $b bmc $g 726563 $s 589720
BAS    __
$a 3
BMC    __
$a 2007 $b 32 $c 4 Aug $d 403-408 $i 0269-4727 $m Journal of clinical pharmacy and therapeutics $n J Clin Pharm Ther $x MED00007277
LZP    __
$a 2010-B2/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...